CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602,000 | +118.9% | 46,943 | +19.8% | 0.09% | +279.2% |
| Q2 2022 | $275,000 | -14.3% | 39,195 | +1.2% | 0.02% | -14.3% |
| Q1 2022 | $321,000 | -74.9% | 38,717 | -86.0% | 0.03% | -67.8% |
| Q2 2020 | $1,279,000 | +1.6% | 276,900 | -15.3% | 0.09% | -13.0% |
| Q1 2020 | $1,259,000 | -15.2% | 327,000 | -17.4% | 0.10% | +8.7% |
| Q4 2019 | $1,484,000 | +51.3% | 395,782 | +114.2% | 0.09% | +58.6% |
| Q3 2019 | $981,000 | – | 184,805 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |